Jane Street’s CNS Pharmaceuticals CNSP Stock Holding History

Jane Street’s Portfolio CNSP Stock Details CNSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-700	Closed	-$50.5K	–	9559
2024 Q4	$50.5K	Buy	700 +661	+1,695%	+$47K	﹤0.01%	8967
2024 Q3	$3.02K	Buy	+39	New	+$11.2K	﹤0.01%	9427
2024 Q2	–	Sell	-1	Closed	-$9.91K	–	9456
2024 Q1	$9.91K	Buy	+1	New	+$14.5K	﹤0.01%	8967
2021 Q2	–	Hold	0	–	-$33K	–	9830
2021 Q1	–	Hold	0	–	–	–	8911

Other funds holding CNSP

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street's CNSP Position: Q1 2025 in Review

Jane Street sold out of CNS Pharmaceuticals (CNSP) in Q1 2025, closing a stake of 700 shares — an estimated $50.5K sold.

Jane Street first reported a position in CNSP in Q1 2024 and held it in 3 quarters. The position peaked at $50.5K in Q4 2024. 7 funds tracked by Wall St. Rank hold CNSP as of Q1 2025.

Jane Street reported no remaining CNS Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Jane Street sold 700 CNS Pharmaceuticals shares in Q1 2025, an estimated $50.5K.
Jane Street first reported a position in CNS Pharmaceuticals in Q1 2024 and held it in 3 quarters.
Jane Street's CNS Pharmaceuticals position peaked at $50.5K in Q4 2024.
7 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.